Reporting the counterparty's growth as its own: management explains the company's coming year by narrating what its cust
The model's full reasoning — Q2 2023 call → NOWe need to determine if management's forward account consists of narrating what its counterparties are themselves doing and scaling, such that the company's own coming volume is presented as a consequence of those parties' own trajectories. Let's examine the transcript. Management discusses various segments. Key points: - NGL and refined products: record volumes, expansion at Nederland, Marcus Hook. They mention "increased international demand for natural gas liquids" and "we continue to export more NGLs than any other company." They talk about demand from international customers. But do they narrate specific counterparties' own build-outs? They mention "second tranche of satellites contract going into effect" - that's a contract, not a counterparty's own scaling. They mention "increased international demand" - that's general market condition. - Lake Charles LNG: They have HOAs with Chesapeake, EQT, Japanese customer. But these are non-binding, subject to negotiation. They are not yet contracted. They are still seeking equity partners. So that's not already inside growth. - Gulf Run: They have sold out capacity by January 2025, and are in discussions to add capacity. They mention "customers" but not specific counterparties' own trajectories. - Carbon capture: with CapturePoint and Oxy, but that's early. - Petchem project: they mention "one equity partner" interested, but not yet FID. - They talk about "we are in discussions with over 500,000 barrels of ethane demand potentially coming online" - that's potential, not current. - They mention "we are very bullish on volumes increasing" but that's general. - They talk about "we have a lot of projects" but not specific counterparties scaling. The question asks: does a substantial part of management's forward account consist of reporting on the growth, expansion, ramp, adoption, or program build-out of specific customers, partners, licensees, distributors, payers, operators, or programs the company ALREADY SUPPLIES OR SERVES? The key is that the company is already inside that growth, and the counterparties' trajectory is early and large. In the transcript, management often speaks about their own projects, their own expansions, their own capacity additions. They mention "we FID-ed an expansion to our NGL export capacity" - that's their own action.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| EMKR | EMCORE Corporation | Q4 2023 | 2023-12-12 | C+ |
| MBLY | Mobileye Global Inc. | Q2 2023 | 2023-07-28 | B+ |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| FNV | Franco-Nevada Corporation | Q3 2016 | 2016-11-08 | B+ |
| HXL | Hexcel Corporation | Q4 2015 | 2016-01-22 | B+ |
OOMA · Q3 2022 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future volume as a consequence of those parties' trajectories.
MBLY · Q2 2023 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's volume as a consequence of those parties' trajectories.
ILMN · Q1 2018 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future as a consequence of those parties' trajectories.